Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: A Southwest Oncology Group study

Jeanne E. Anderson, Kenneth J. Kopecky, Cheryl L. Willman, David Head, Margaret R. O'Donnell, Frederick W. Luthardt, Thomas H. Norwood, I. Ming Chen, Stanley P. Balcerzak, David B. Johnson, Frederick R. Appelbaum

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: A Southwest Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds